1. Home
  2. BMRA vs NUKK Comparison

BMRA vs NUKK Comparison

Compare BMRA & NUKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRA
  • NUKK
  • Stock Information
  • Founded
  • BMRA 1971
  • NUKK 2013
  • Country
  • BMRA United States
  • NUKK United States
  • Employees
  • BMRA N/A
  • NUKK N/A
  • Industry
  • BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • NUKK Blank Checks
  • Sector
  • BMRA Health Care
  • NUKK Finance
  • Exchange
  • BMRA Nasdaq
  • NUKK Nasdaq
  • Market Cap
  • BMRA 7.4M
  • NUKK 6.3M
  • IPO Year
  • BMRA N/A
  • NUKK N/A
  • Fundamental
  • Price
  • BMRA $0.33
  • NUKK $1.87
  • Analyst Decision
  • BMRA
  • NUKK
  • Analyst Count
  • BMRA 0
  • NUKK 0
  • Target Price
  • BMRA N/A
  • NUKK N/A
  • AVG Volume (30 Days)
  • BMRA 337.1K
  • NUKK 830.5K
  • Earning Date
  • BMRA 10-15-2024
  • NUKK 11-29-2024
  • Dividend Yield
  • BMRA N/A
  • NUKK N/A
  • EPS Growth
  • BMRA N/A
  • NUKK N/A
  • EPS
  • BMRA N/A
  • NUKK N/A
  • Revenue
  • BMRA $5,509,000.00
  • NUKK $10,752,616.00
  • Revenue This Year
  • BMRA N/A
  • NUKK N/A
  • Revenue Next Year
  • BMRA N/A
  • NUKK N/A
  • P/E Ratio
  • BMRA N/A
  • NUKK N/A
  • Revenue Growth
  • BMRA 1.74
  • NUKK N/A
  • 52 Week Low
  • BMRA $0.24
  • NUKK $1.30
  • 52 Week High
  • BMRA $2.13
  • NUKK $79.03
  • Technical
  • Relative Strength Index (RSI)
  • BMRA 45.05
  • NUKK 41.68
  • Support Level
  • BMRA $0.34
  • NUKK $2.23
  • Resistance Level
  • BMRA $0.44
  • NUKK $3.33
  • Average True Range (ATR)
  • BMRA 0.04
  • NUKK 0.48
  • MACD
  • BMRA -0.00
  • NUKK -0.05
  • Stochastic Oscillator
  • BMRA 23.21
  • NUKK 28.09

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.

About NUKK Nukkleus Inc.

Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically, the majority of its revenue is generated from the United Kingdom and the rest from the United States and Malta.

Share on Social Networks: